ulcid 20 milligram capsules gastro-resistant
astellas pharma co. ltd - omeprazole - capsules gastro-resistant - 20 milligram
vesitirim 5 mg film-coated tablets
astellas pharma co. limited - solifenacin succinate - film-coated tablet - 5 milligram(s) - drugs for urinary frequency and incontinence; solifenacin
vesitirim 10 mg film-coated tablets
astellas pharma co. limited - solifenacin succinate - film-coated tablet - 10 milligram(s) - drugs for urinary frequency and incontinence; solifenacin
prograf 0.5mg hard capsules
astellas pharma europe b.v. - tacrolimus - hard capsule - tacrolimus milligram(s) - immunosuppressants
prograf 1mg hard capsules
astellas pharma europe b.v. - tacrolimus - hard capsule - tacrolimus 1 milligram(s) - immunosuppressants
prograf 5mg hard capsules
astellas pharma europe b.v. - tacrolimus - hard capsule - tacrolimus 5 milligram(s) - immunosuppressants
prograf 5mg/ml concentrate for solution for infusion
astellas pharma europe b.v. - tacrolimus - concentrate for solution for infusion - tacrolimus 5 milligram(s)/millilitre - immunosuppressants
xtandi
astellas pharma europe b.v. - enzalutamide - prostatic neoplasms - endocrine therapy - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5.1).the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5.1).the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5.1).the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
prograf 500microgram capsules
astellas pharma ltd - tacrolimus - oral capsule - 500microgram
prograf 1mg capsules
astellas pharma ltd - tacrolimus - oral capsule - 1mg